ReviewFrontiers in cell and developmental biology2025
The role of HERV envelope protein in ovarian cancer.
Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.Retrovirology · 2026Article
- Organoids in biliary research: insights into developmental signaling and applications in disease modeling.Frontiers in cell and developmental biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human endogenous retroviruses (HERVs) are a remnant of repeated exogenous retroviral infections in human ancestors, which have been integrated into germline cells and proliferated through retrotransposition, recombination, and reinfection. Comprising approximately 8% of the human genome, HERV genes are capable of upregulating the expression of their encoded gene products in response to both endogenous and exogenous stimuli. Among HERV gene products, the envelope (env) proteins are currently extensively investigated for their pathogenic properties in cancer. Given that HERV was initially discovered in the germline cells and the ovary is an essential female reproductive organ, this review will focus on the current knowledge of the role of HERV env protein in ovarian cancer (OC). Our review systematically delineates the expression of HERV env protein across different histological subtypes of OC and highlights its pivotal roles in tumorigenesis and cancer progression. Elucidating the role of HERV env protein in OC offers novel perspectives for developing diagnostic approaches and therapeutic monitoring strategies in OC management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.